Systemically administered neurotensin receptor agonist produces antinociception through activation of spinally projecting serotonergic neurons in the rostral ventromedial medulla
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Supraspinal delivery of neurotensin (NTS), which may contribute to the effect of a systemically administered agonist, has been reported to be either pronociceptive or antinociceptive. Here, we evaluated the effects of systemically administered NTSR1 agonist in a rat model of neuropathic pain and elucidated the underlying supraspinal mechanism. Methods: Neuropathic pain was induced by L5 and L6 spinal nerve ligation in male Sprague–Dawley rats. The effects of intraperitoneally administered NTSR1 agonist PD 149163 was assessed using von Frey filaments. To examine the role of 5-HT neurotransmission, a serotonin (5-HT) receptor antagonist dihydroergocristine was pretreated intrathecally, and spinal microdialysis studies were performed to measure the change in extracellular level of 5-HT in response to PD 149163 administration. To investigate the supraspinal mechanism, NTSR1 antagonist 48692 was microinjected into the rostral ventromedial medulla (RVM) prior to systemic PD 149163. Additionally, the effect of intrathecal DHE on intra-RVM PD 149163 was assessed. Results: Intraperitoneally administered PD 149163 exhibited a dose-dependent attenuation of mechanical allodynia. This effect was partially reversed by intrathecal pretreatment with dihydroergocristine and was accompanied by an increased extracellular level of 5-HT in the spinal cord. The PD 149163-produced antinociception was also blocked by intra-RVM SB 48692. Direct injection of PD 149163 into the RVM mimicked the maximum effect of the same drug delivered intraperitoneally, which was reversed by intrathecal dihydroergocristine. Conclusions: These observations indicate that systemically administered NTSR1 agonist produces antinociception through the NTSR1 in the RVM, activating descending serotonergic projection to release 5-HT into the spinal dorsal horn.
Abstract
Background: Supraspinal delivery of neurotensin (NTS), which may contribute to the effect of a systemically administered agonist, has been reported to be either pronociceptive or antinociceptive. Here, we evaluated the effects of systemically administered NTSR1 agonist in a rat model of neuropathic pain and elucidated the underlying supraspinal mechanism. Methods: Neuropathic pain was induced by L5 and L6 spinal nerve ligation in male Sprague–Dawley rats. The effects of intraperitoneally administered NTSR1 agonist PD 149163 was assessed using von Frey filaments. To examine the role of 5-HT neurotransmission, a serotonin (5-HT) receptor antagonist dihydroergocristine was pretreated intrathecally, and spinal microdialysis studies were performed to measure the change in extracellular level of 5-HT in response to PD 149163 administration. To investigate the supraspinal mechanism, NTSR1 antagonist 48692 was microinjected into the rostral ventromedial medulla (RVM) prior to systemic PD 149163. Additionally, the effect of intrathecal DHE on intra-RVM PD 149163 was assessed. Results: Intraperitoneally administered PD 149163 exhibited a dose-dependent attenuation of mechanical allodynia. This effect was partially reversed by intrathecal pretreatment with dihydroergocristine and was accompanied by an increased extracellular level of 5-HT in the spinal cord. The PD 149163-produced antinociception was also blocked by intra-RVM SB 48692. Direct injection of PD 149163 into the RVM mimicked the maximum effect of the same drug delivered intraperitoneally, which was reversed by intrathecal dihydroergocristine. Conclusions: These observations indicate that systemically administered NTSR1 agonist produces antinociception through the NTSR1 in the RVM, activating descending serotonergic projection to release 5-HT into the spinal dorsal horn.
참고문헌 (26)
- Carraway R, "The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami", J Biol Chem, 248, pp.6854~6861 (1973)
- Mustain WC, "The role of neurotensin in physiologic and pathologic processes", Curr Opin Endocrinol Diabetes Obes, 18, pp.75~82 (2011)
- Boules M, "Diverse roles of neurotensin agonists in the central nervous system", Front Endocrinol (Lausanne), 4, pp.36~ (2013)
- Kleczkowska P, "Neurotensin and neurotensin receptors : characteristic, structure-activity relationship and pain modulation--a review", Eur J Pharmacol, 716, pp.54~60 (2013)
- Fassio A, "Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody", Neuropharmacology, 39, pp.1430~1442 (2000)
- Buhler AV, "Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive", Pain, 114, pp.285~294 (2005)
- Roussy G, "Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model", J Neurochem, 105, pp.1100~1114 (2008)
- Guillemette A, "Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain", Eur J Pain, 16, pp.473~484 (2012)
- Holmes BB, "Supraspinal neurotensin-induced antianalgesia in mice is mediated by spinal cholecystokinin", Jpn J Pharmacol, 79, pp.141~149 (1999)
- Urban MO, "Localization of the antinociceptive and antianalgesic effects of neurotensin within the rostral ventromedial medulla", Neurosci Lett, 174, pp.21~25 (1994)
- Smith DJ, "Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: influence on the antinociceptive effect of morphine", J Pharmacol Exp Ther, 282, pp.899~908 (1997)
- Urban MO, "Biphasic modulation of visceral nociception by neurotensin in rat rostral ventromedial medulla", J Pharmacol Exp Ther, 290, pp.207~213 (1999)
- Kim SH, "An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat", Pain, 50, pp.355~363 (1992)
- Gi-Ho Koh, "Effect of sec-O-glucosylhamaudol on mechanical allodynia in a rat model of postoperative pain", The Korean Journal of Pain, 32(2), pp.87~96 (2019), 대한통증학회[DOI]
- Chaplan SR, "Quantitative assessment of tactile allodynia in the rat paw", J Neurosci Methods, 53, pp.55~63 (1994)
- Mei Yin, "Antinociceptive role of neurotensin receptor 1 in rats with chemotherapy-induced peripheral neuropathy", The Korean Journal of Pain, 33(4), pp.318~325 (2020), 대한통증학회[DOI]
- Lee HG, "The antiallodynic effect of intrathecal tianeptine is exerted by increased serotonin and norepinephrine in the spinal dorsal horn", Neurosci Lett, 583, pp.103~107 (2014)
- Chae JW, "Antinociceptive effects of nefopam modulating serotonergic, adrenergic, and glutamatergic neurotransmission in the spinal cord", Neurosci Lett, 731, pp.135057~ (2020)
- Paxinos G, "Paxinos and Watson’s the rat brain in stereotaxic coordinates", pp.116~132 (2014), Academic Press
- Bodnar RJ, "The effects of centrally administered antisera to neurotensin and related peptides upon nociception and related behaviors", Ann N Y Acad Sci, 400, pp.244~258 (1982)
- Millan MJ, "Descending control of pain", Prog Neurobiol, 66, pp.355~474 (2002)
- Mason P, "Central mechanisms of pain modulation", Curr Opin Neurobiol, 9, pp.436~441 (1999)
- Wang QP, "The dorsal raphe : an important nucleus in pain modulation", Brain Res Bull, 34, pp.575~585 (1994)
- Fang FG, "Dose-dependent antinociceptive action of neurotensin microinjected into the rostroventromedial medulla of the rat", Brain Res, 420, pp.171~174 (1987)
- Costa-Pereira JT, "Serotoninergic pain modulation from the rostral ventromedial medulla(RVM)in chemotherapy-induced neuropathy : the role of spinal 5-HT3 receptors", Eur J Neurosci, 51, pp.1756~1769 (2020)
- Behbehani MM, "Physiological mechanisms of the analgesic effect of neurotensin", Ann N Y Acad Sci, 668, pp.253~265 (1992)